Nalphin Injection 20 mg/ml contains Nalbuphine, a semi-synthetic opioid analgesic used for the management of moderate to severe pain. It is a potent parenteral formulation intended for intravenous (IV), intramuscular (IM), or subcutaneous (SC) administration, providing rapid and effective pain relief in hospital and clinical settings. Nalphin is a mixed agonist-antagonist opioid, offering analgesic benefits while minimizing certain opioid-related risks such as respiratory depression and dependence.
Nalbuphine works by selectively activating kappa-opioid receptors in the central nervous system, producing analgesia, while acting as a partial antagonist at mu-opioid receptors. This dual mechanism provides effective pain control with a reduced potential for euphoria and abuse. The high concentration of 20 mg/ml allows precise dosing, making it ideal for acute pain management, post-operative analgesia, and labor pain relief.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Nalphin Injection 20 mg/ml is indicated for:
Management of moderate to severe acute pain, including post-operative and trauma-related pain
Pain relief during labor and delivery
Analgesia in patients requiring parenteral opioid therapy in clinical or hospital settings
It is important to note that Nalphin is not intended for long-term pain management or for use in outpatient self-administration without medical supervision.
The dosage of Nalphin Injection depends on the severity of pain, route of administration, and patient response:
Adults: 10–20 mg IV, IM, or SC every 3–6 hours as needed for pain. IV injections should be administered slowly to reduce the risk of adverse effects.
Elderly or debilitated patients: Lower doses or extended dosing intervals may be necessary.
Doses should be titrated by healthcare professionals to achieve optimal analgesia while minimizing potential side effects. Continuous monitoring is recommended when administering IV injections to assess for sedation, respiratory status, and blood pressure changes.
Use cautiously in patients with respiratory disorders such as asthma or chronic obstructive pulmonary disease, as opioids may cause respiratory depression.
Avoid in patients with head injury, increased intracranial pressure, or impaired consciousness.
Dose adjustment may be required for patients with liver or kidney impairment.
Concomitant use with CNS depressants, sedatives, or alcohol may enhance sedative or respiratory effects.
Not recommended during pregnancy or lactation unless clearly necessary and under medical supervision.
Monitor for potential dependence or abuse, though risk is lower than with pure mu-opioid agonists.
Nalphin Injection 20 mg/ml is generally well tolerated. Common side effects include:
Sedation or drowsiness
Dizziness
Nausea and vomiting
Sweating
Headache
Rare but serious effects may include hypotension, bradycardia, respiratory depression, or severe allergic reactions. Immediate medical attention is required if severe reactions occur.
Store below 30°C in a cool, dry place, protected from light. Keep out of reach of children.
Nalphin Injection 20 mg/ml provides rapid, potent analgesia for moderate to severe pain in hospital settings. Its mixed agonist-antagonist profile ensures effective pain relief with a reduced risk of respiratory depression and abuse, making it an essential option for acute pain management.
Login Or Registerto submit your questions to seller
No none asked to seller yet